0000914190-20-000276.txt : 20200811
0000914190-20-000276.hdr.sgml : 20200811
20200811173852
ACCESSION NUMBER: 0000914190-20-000276
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200807
FILED AS OF DATE: 20200811
DATE AS OF CHANGE: 20200811
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Points Jeffrey S.
CENTRAL INDEX KEY: 0001731414
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52082
FILM NUMBER: 201093553
MAIL ADDRESS:
STREET 1: C/O CARDIOVASCULAR SYSTEMS, INC.
STREET 2: 1225 OLD HIGHWAY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardiovascular Systems Inc
CENTRAL INDEX KEY: 0001180145
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411698056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 1225 OLD HWY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
BUSINESS PHONE: 651-259-1600
MAIL ADDRESS:
STREET 1: 1225 OLD HWY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
FORMER COMPANY:
FORMER CONFORMED NAME: REPLIDYNE INC
DATE OF NAME CHANGE: 20020813
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-08-07
0001180145
Cardiovascular Systems Inc
CSII
0001731414
Points Jeffrey S.
1225 OLD HIGHWAY 8 NW
ST. PAUL
MN
55112
0
1
0
0
Chief Financial Officer
Common Stock
2020-08-07
4
A
0
8557
0
A
59170
D
Common Stock
2020-08-07
4
A
0
25671
0
A
84841
D
Restrictions lapse as to 2,853 shares on 8/13/21 and as to 2,852 shares on each of 8/13/22 and 8/13/23.
Subject to performance-based forfeiture based on the Company's three-year total shareholder return for fiscal years 2021, 2022 and 2023 versus the Company's peer group.
/s/ Amanda Lorentz as Attorney-in-Fact for Jeffrey S. Points pursuant to Power of Attorney previously filed.
2020-08-11